Insider Trading activities of Bluebird Bio, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bluebird Bio, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bluebird Bio, Inc. since year 2005. Table 2 shows the detailed insider transactions of Bluebird Bio, Inc. since 2005. The reporting company's ticker symbol is BLUE. The reporting company's CIK number is 1293971.
The total value of stock buying since 2005 is $900,936.
The total value of stock sales since 2005 is $173,179,258.
The total value of stock option exercises since 2005 is $5,898,370.


 1   2 
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Bluebird Bio, Inc. (BLUE).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-05 0 $0 5,750 $510,053 5,000 $51,027
2017-04 0 $0 7,250 $646,368 11,000 $103,890
2017-03 0 $0 43,185 $3,903,048 42,774 $495,201
2017-02 0 $0 14,723 $1,169,021 10,000 $171,288
2017-01 0 $0 25,810 $1,823,876 20,000 $293,216
2016-10 0 $0 416 $27,870 416 $9,395
2016-09 0 $0 416 $24,544 416 $9,395
2016-08 0 $0 416 $24,544 416 $9,395
2016-07 0 $0 6,719 $332,095 3,912 $67,857
2016-06 0 $0 3,931 $155,945 20,826 $77,290
2016-05 0 $0 1,000 $38,729 1,000 $2,090
2016-04 0 $0 1,000 $49,630 1,000 $2,090
2016-03 0 $0 1,000 $46,366 1,000 $2,090
2016-02 0 $0 1,000 $45,176 1,000 $2,090
2016-01 0 $0 1,000 $44,392 1,000 $2,090
2015-12 9,682 $501,062 1,416 $92,297 72,574 $326,578
2015-11 0 $0 2,416 $174,677 2,416 $13,575
2015-10 0 $0 21,416 $1,905,528 21,416 $155,473
2015-09 0 $0 150,416 $20,189,663 150,416 $856,510
2015-08 0 $0 171,416 $24,507,739 171,416 $578,306
2015-07 0 $0 19,542 $3,133,580 18,416 $149,215
2015-06 0 $0 30,416 $5,677,588 30,416 $448,675
2015-05 0 $0 67,416 $10,523,276 67,416 $461,230
2015-04 0 $0 85,998 $10,500,314 85,998 $292,148
2015-03 0 $0 24,500 $2,669,933 24,500 $255,605
2015-02 0 $0 14,500 $1,283,044 14,500 $30,289
2015-01 0 $0 48,250 $4,493,426 48,250 $160,522
2014-12 3,528 $299,880 86,751 $5,235,273 79,500 $145,562
2014-11 0 $0 35,500 $1,478,228 10,500 $21,932
2014-10 0 $0 318,423 $11,298,711 45,018 $94,086
2014-09 0 $0 318,595 $11,672,957 28,500 $39,044
2014-08 0 $0 20,800 $718,791 10,500 $21,944
2014-07 2,941 $99,994 32,783 $1,255,780 10,500 $21,944
2014-06 0 $0 93,500 $3,358,237 28,500 $39,045
2014-05 0 $0 15,000 $294,980 126,266 $263,895
2014-04 0 $0 15,000 $332,399 10,000 $20,900
2014-03 0 $0 29,500 $737,365 24,500 $42,085
2014-02 0 $0 24,000 $512,944 19,000 $39,709
2014-01 0 $0 1,837,500 $41,568,121 38,500 $69,065
2013-12 0 $0 35,000 $722,750 35,000 $52,629

Table 2. Detailed insider stock purchases, sales, and option exercises of Bluebird Bio, Inc. insiders (BLUE)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-05-10 Walsh Jeffrey T. (Chief Financial) Sale 1,250 89.10 111,377
2017-05-10 Walsh Jeffrey T. (Chief Financial) Option Ex 1,250 5.50 6,875
2017-05-01 Davidson David (Chief Medical Officer) Sale 3,000 88.74 266,220
2017-05-01 Davidson David (Chief Medical Officer) Option Ex 3,000 2.09 6,270
2017-05-01 Gregory Philip D (Chief Scientific Officer) Sale 1,500 88.30 132,456
2017-05-01 Gregory Philip D (Chief Scientific Officer) Option Ex 750 50.51 37,882
2017-04-27 Lynch Daniel (Director) Sale 1,000 90.01 90,010
2017-04-27 Lynch Daniel (Director) Option Ex 1,000 2.09 2,086
2017-04-26 Cole Jason (Chief Legal Officer) Option Ex 3,750 22.53 84,487
2017-04-25 Lynch Daniel (Director) Sale 2,000 86.75 173,500
2017-04-25 Lynch Daniel (Director) Option Ex 2,000 2.09 4,172
2017-04-10 Walsh Jeffrey T. (Chief Financial) Sale 1,250 87.38 109,225
2017-04-10 Walsh Jeffrey T. (Chief Financial) Option Ex 1,250 5.50 6,875
2017-04-03 Davidson David (Chief Medical Officer) Sale 3,000 91.21 273,633
2017-04-03 Davidson David (Chief Medical Officer) Option Ex 3,000 2.09 6,270
2017-03-27 Lynch Daniel (Director) Sale 1,000 90.00 90,000
2017-03-27 Lynch Daniel (Director) Option Ex 1,000 2.09 2,086
2017-03-24 Lynch Daniel (Director) Sale 2,000 87.37 174,732
2017-03-24 Lynch Daniel (Director) Option Ex 2,000 2.09 4,172
2017-03-16 Sullivan Eric (Principal Accounting Officer) Sale 411 99.00 40,689
2017-03-16 Walsh Jeffrey T. (Chief Financial) Sale 3,543 100.07 354,562
2017-03-16 Walsh Jeffrey T. (Chief Financial) Option Ex 3,543 3.79 13,445
2017-03-16 Cole Jason (Chief Legal Officer) Sale 4,930 100.07 493,364
2017-03-16 Cole Jason (Chief Legal Officer) Option Ex 4,930 22.53 111,072
2017-03-16 Lynch Daniel (Director) Sale 237 100.07 23,717
2017-03-16 Lynch Daniel (Director) Option Ex 237 2.09 494
2017-03-03 Maraganore John (Director) Sale 13,839 85.02 1,176,647
2017-03-03 Maraganore John (Director) Option Ex 13,839 3.22 44,616
2017-03-01 Davidson David (Chief Medical Officer) Sale 5,000 89.83 449,155
2017-03-01 Davidson David (Chief Medical Officer) Option Ex 5,000 2.09 10,450
2017-03-01 Schenkein David P (Director) Sale 5,000 89.53 447,635
2017-03-01 Schenkein David P (Director) Option Ex 5,000 8.16 40,780
2017-03-01 Cole Jason (Chief Legal Officer) Sale 5,225 90.32 471,911
2017-03-01 Cole Jason (Chief Legal Officer) Option Ex 5,225 50.51 263,914
2017-03-01 Lynch Daniel (Director) Sale 2,000 90.32 180,636
2017-03-01 Lynch Daniel (Director) Option Ex 2,000 2.09 4,172
2017-02-28 Sullivan Eric (Principal Accounting Officer) Sale 285 89.00 25,365
2017-02-15 Mandell James (Director) Sale 1,050 80.22 84,235
2017-02-15 Mandell James (Director) Option Ex 1,050 25.16 26,418
2017-02-15 Cole Jason (Chief Legal Officer) Sale 666 80.22 53,429
2017-02-15 Lynch Daniel (Director) Sale 150 80.22 12,033
2017-02-15 Lynch Daniel (Director) Option Ex 150 2.09 312
2017-02-14 Mandell James (Director) Sale 5,950 80.01 476,077
2017-02-14 Mandell James (Director) Option Ex 5,950 23.30 138,605
2017-02-14 Cole Jason (Chief Legal Officer) Sale 3,772 80.01 301,809
2017-02-14 Lynch Daniel (Director) Sale 850 80.01 68,011
2017-02-14 Lynch Daniel (Director) Option Ex 850 2.09 1,773
2017-02-01 Davidson David (Chief Medical Officer) Sale 2,000 74.03 148,062
2017-02-01 Davidson David (Chief Medical Officer) Option Ex 2,000 2.09 4,180
2017-01-31 Mandell James (Director) Sale 8,000 75.04 600,320
2017-01-31 Mandell James (Director) Option Ex 8,000 21.43 171,440
2017-01-27 Mandell James (Director) Sale 5,000 70.10 350,500
2017-01-27 Mandell James (Director) Option Ex 5,000 21.43 107,150
2017-01-27 Davidson David (Chief Medical Officer) Sale 6,000 68.85 413,117
2017-01-27 Davidson David (Chief Medical Officer) Option Ex 6,000 2.09 12,540
2017-01-27 Lynch Daniel (Director) Sale 1,000 70.09 70,092
2017-01-27 Lynch Daniel (Director) Option Ex 1,000 2.09 2,086
2017-01-05 Sullivan Eric (Principal Accounting Officer) Sale 229 67.10 15,365
2017-01-05 Davidson David (Chief Medical Officer) Sale 923 67.10 61,933
2017-01-05 Leschly Nick (President and CEO) Sale 2,024 67.10 135,810
2017-01-05 Walsh Jeffrey T. (Chief Financial) Sale 1,295 67.10 86,894
2017-01-05 Cole Jason (Chief Legal Officer) Sale 549 67.10 36,837
2017-01-05 Gregory Philip D (Chief Scientific Officer) Sale 790 67.10 53,008
2016-10-03 Sullivan Eric (Principal Accounting Officer) Sale 416 67.00 27,870
2016-10-03 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2016-09-13 Sullivan Eric (Principal Accounting Officer) Sale 416 59.00 24,544
2016-09-13 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2016-08-03 Sullivan Eric (Principal Accounting Officer) Sale 416 59.00 24,544
2016-08-03 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2016-07-27 Sullivan Eric (Principal Accounting Officer) Sale 2,912 55.01 160,177
2016-07-27 Sullivan Eric (Principal Accounting Officer) Option Ex 2,912 22.59 65,767
2016-07-20 Sullivan Eric (Principal Accounting Officer) Sale 1,950 45.09 87,933
2016-07-19 Sullivan Eric (Principal Accounting Officer) Sale 857 45.40 38,907
2016-07-15 Davidson David (Chief Medical Officer) Sale 1,000 45.08 45,078
2016-07-15 Davidson David (Chief Medical Officer) Option Ex 1,000 2.09 2,090
2016-06-24 Leschly Nick (President and CEO) Option Ex 19,826 3.79 75,200
2016-06-16 Gregory Philip D (Chief Scientific Officer) Sale 2,931 39.52 115,833
2016-06-15 Davidson David (Chief Medical Officer) Sale 1,000 40.11 40,112
2016-06-15 Davidson David (Chief Medical Officer) Option Ex 1,000 2.09 2,090
2016-05-16 Davidson David (Chief Medical Officer) Sale 1,000 38.73 38,729
2016-05-16 Davidson David (Chief Medical Officer) Option Ex 1,000 2.09 2,090
2016-04-15 Davidson David (Chief Medical Officer) Sale 1,000 49.63 49,630
2016-04-15 Davidson David (Chief Medical Officer) Option Ex 1,000 2.09 2,090
2016-03-15 Davidson David (Chief Medical Officer) Sale 1,000 46.37 46,366
2016-03-15 Davidson David (Chief Medical Officer) Option Ex 1,000 2.09 2,090
2016-02-16 Davidson David (Chief Medical Officer) Sale 1,000 45.18 45,176
2016-02-16 Davidson David (Chief Medical Officer) Option Ex 1,000 2.09 2,090
2016-01-15 Davidson David (Chief Medical Officer) Sale 1,000 44.39 44,392
2016-01-15 Davidson David (Chief Medical Officer) Option Ex 1,000 2.09 2,090
2015-12-21 Cole Jason (SVP, Secy. & General Counsel) Option Ex 4,438 22.53 99,988
2015-12-15 Davidson David (Chief Medical Officer) Sale 1,000 58.55 58,546
2015-12-15 Davidson David (Chief Medical Officer) Option Ex 1,000 2.09 2,090
2015-12-08 Leschly Nick (President and CEO) Buy 9,682 51.75 501,062
2015-12-07 Leschly Nick (President and CEO) Option Ex 66,720 3.22 215,105
2015-12-02 Sullivan Eric (Principal Accounting Officer) Sale 416 81.13 33,751
2015-12-02 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2015-11-16 Davidson David (Chief Medical Officer) Sale 2,000 71.14 142,284
2015-11-16 Davidson David (Chief Medical Officer) Option Ex 2,000 2.09 4,180
2015-11-02 Sullivan Eric (Principal Accounting Officer) Sale 416 77.87 32,393
2015-11-02 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2015-10-15 Davidson David (Chief Medical Officer) Sale 2,000 79.93 159,866
2015-10-15 Davidson David (Chief Medical Officer) Option Ex 2,000 2.09 4,180
2015-10-12 Walsh Jeffrey T. (Chief Operating Officer) Sale 11,000 88.34 971,696
2015-10-12 Walsh Jeffrey T. (Chief Operating Officer) Option Ex 11,000 2.09 22,990
2015-10-09 Cole Jason (SVP, Secy. & General Counsel) Sale 5,000 87.20 436,019
2015-10-09 Cole Jason (SVP, Secy. & General Counsel) Option Ex 5,000 22.53 112,650
2015-10-05 Lynch Daniel (Director) Sale 3,000 100.69 302,070
2015-10-05 Lynch Daniel (Director) Option Ex 3,000 2.09 6,258
2015-10-02 Sullivan Eric (Principal Accounting Officer) Sale 416 86.24 35,877
2015-10-02 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2015-09-17 Lynch Daniel (Director) Sale 1,500 140.06 210,088
2015-09-17 Lynch Daniel (Director) Option Ex 1,500 2.09 3,129
2015-09-15 Davidson David (Chief Medical Officer) Sale 2,000 130.75 261,495
2015-09-15 Davidson David (Chief Medical Officer) Option Ex 2,000 2.09 4,180
2015-09-10 Walsh Jeffrey T. (Chief Operating Officer) Sale 11,000 129.62 1,425,875
2015-09-10 Walsh Jeffrey T. (Chief Operating Officer) Option Ex 11,000 5.50 60,500
2015-09-09 Cole Jason (SVP, Secy. & General Counsel) Sale 2,000 136.84 273,684
2015-09-09 Cole Jason (SVP, Secy. & General Counsel) Option Ex 2,000 22.53 45,060
2015-09-08 Leschly Nick (President and CEO) Sale 125,000 134.78 16,847,250
2015-09-08 Leschly Nick (President and CEO) Option Ex 125,000 5.50 687,500
2015-09-08 Lynch Daniel (Director) Sale 7,000 132.49 927,437
2015-09-08 Lynch Daniel (Director) Option Ex 7,000 2.09 14,601
2015-09-02 Sullivan Eric (Principal Accounting Officer) Sale 416 130.94 54,471
2015-09-02 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2015-09-01 Mandell James (Director) Sale 1,500 126.24 189,363
2015-09-01 Mandell James (Director) Option Ex 1,500 21.43 32,145
2015-08-17 Davidson David (Chief Medical Officer) Sale 2,000 125.83 251,664
2015-08-17 Davidson David (Chief Medical Officer) Option Ex 2,000 2.09 4,180
2015-08-10 Mandell James (Director) Sale 1,500 149.72 224,580
2015-08-10 Mandell James (Director) Option Ex 1,500 21.43 32,145
2015-08-10 Walsh Jeffrey T. (Chief Operating Officer) Sale 11,000 149.72 1,646,942
2015-08-10 Walsh Jeffrey T. (Chief Operating Officer) Option Ex 11,000 2.09 22,990
2015-08-10 Cole Jason (SVP, Secy. & General Counsel) Sale 2,000 149.72 299,446
2015-08-10 Cole Jason (SVP, Secy. & General Counsel) Option Ex 2,000 22.53 45,060
2015-08-07 Leschly Nick (President and CEO) Sale 125,000 142.25 17,781,125
2015-08-07 Leschly Nick (President and CEO) Option Ex 125,000 3.22 403,000
2015-08-07 Lynch Daniel (Director) Sale 29,500 143.56 4,235,108
2015-08-07 Lynch Daniel (Director) Option Ex 29,500 2.09 61,536
2015-08-03 Sullivan Eric (Principal Accounting Officer) Sale 416 165.56 68,874
2015-08-03 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
2015-07-20 Sullivan Eric (Principal Accounting Officer) Sale 682 163.25 111,337
2015-07-17 Sullivan Eric (Principal Accounting Officer) Sale 444 164.58 73,074
2015-07-15 Davidson David (Chief Medical Officer) Sale 2,000 166.44 332,880
2015-07-15 Davidson David (Chief Medical Officer) Option Ex 2,000 2.09 4,180
2015-07-10 Walsh Jeffrey T. (Chief Operating Officer) Sale 11,000 159.82 1,758,042
2015-07-10 Walsh Jeffrey T. (Chief Operating Officer) Option Ex 11,000 2.09 22,990
2015-07-09 Cole Jason (SVP, Secy. & General Counsel) Sale 5,000 158.05 790,245
2015-07-09 Cole Jason (SVP, Secy. & General Counsel) Option Ex 5,000 22.53 112,650
2015-07-02 Sullivan Eric (Principal Accounting Officer) Sale 416 163.47 68,002
2015-07-02 Sullivan Eric (Principal Accounting Officer) Option Ex 416 22.59 9,395
 1   2 

Insider trading activities including stock purchases, stock sales, and option exercises of BLUE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bluebird Bio, Inc. (symbol BLUE, CIK number 1293971) see the Securities and Exchange Commission (SEC) website.